Management of an Imipenem-resistant Acinetobacter Baumannii Alert in a French University Hospital
Recruiting
- Conditions
- Acinetobacter Baumannii
- Registration Number
- NCT06173440
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
Colonization with imipenem-resistant Acinetobacter baumannii (IBA) is an unfavorable event for the patient, especially in intensive care. Indeed, it exposes the patient to the risk of developing serious infections, extremely difficult to treat. ABRI is a particularly resistant bacterium in the environment. When an ABRI epidemic occurs in a department as central to the hospital as a surgical resuscitation department, the control of such an event can be extremely complex. There are few clear and detailed descriptions in the literature of how to manage this type of outbreak, let alone an ABRI outbreak of this magnitude.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 148
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retrospective description of the management of an imipenem-resistant Acinetobacter baumannii outbreak that occurred from 2015 to 2019 in a surgical intensive care unit Through study completion, an average of 5 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Service Equipe opérationnelle d'hygiène - CHU de Strasbourg - France
🇫🇷Strasbourg, France